Left ventricular global longitudinal strain in secondary hypertension: A meta-analysis of echocardiographic studies

Published:October 26, 2021DOI:https://doi.org/10.1016/j.ejim.2021.10.018

      Highlights

      • Ejection fraction was similar between patients with secondary and essential hypertension.
      • Left ventricular mass index was higher in patients with secondary hypertension comparing with essential hypertension.
      • Left ventricular global longitudinal strain was lower in patients with secondary hypertension than in essential hypertensives.

      Abstract

      Aim

      Information on systolic dysfunction, as assessed by left ventricular (LV) mechanics in secondary hypertension is still largely limited. We performed a systematic meta- analysis of 2D/3D speckle tracking studies in order to provide an updated comprehensive information on this topic.

      Methods

      The PubMed, OVID-MEDLINE, and Cochrane library databases were analysed to search for articles published from the inception up to March 31st 2021. Studies were identified by using MeSH terms and crossing the following search items: “myocardial strain” “left ventricular mechanics”, “speckle tracking echocardiography”, “systolic dysfunction”, “hypertensive heart disease”, “left ventricular hypertrophy”, “secondary hypertension”, “primary aldosteronism”, “pheochromocytoma”, “Cushing disease”, “renal artery stenosis”.

      Results

      On the whole, 515 patients with secondary hypertension (169 pheochromocytoma, 165 primary aldosteronism, 144 renal artery stenosis and 37 Cushing's syndrome) and 601 essential hypertensive patients from 11 studies were considered. Pooled ejection fraction (EF) was similar in essential hypertensive controls and in patients with secondary hypertension (SMD 0.12±0.06, CI: 0.001/0.25, p=0.05). Of note, EF was higher in patients with pheochromocytoma than in essential hypertensives (0.50±0.11, CI: 0.27/0.73, p<0.001). In contrast, pooled GLS was impaired in patients with secondary hypertension compared to their essential hypertensive counterparts (SMD 0.83±0.26, CI: 0.32/1.30, p< 0.001).

      Conclusions

      The present meta-analysis adds a new piece of evidence by showing that GLS performs better than EF in identifying systolic dysfunction in the setting of secondary hypertension. In particular, this is true in patients with pheochromocytoma in whom conventional EF suggests a normal or even super-normal systolic function.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      References

        • Agabiti-Rosei E
        • Muiesan M
        • Cuspidi C.
        Cardiac damage from left ventricular hypertrophy to heart failure.
        in: Mancia G Grassi G Tsioufis KP Dominiczak AF Agabiti- Rosei E Manual of hypertension of the european society of hypertension. Taylor & Francis, 2019: 225-240
        • Williams B
        • Mancia G
        • Spiering W
        • Agabiti Rosei E
        • Azizi M
        • Burnier M
        • Clement D
        • Coca A
        • De Simone G
        • Dominiczak A
        • Kahan T
        • Mahfoud F
        • Redon J
        • Ruilope L
        • Zanchetti A
        • Kerins M
        • Kjeldsen S
        • Kreutz R
        • Laurent S
        • Lip GYH
        • McManus R
        • Narkiewicz K
        • Ruschitzka F
        • Schmieder R
        • Shlyakhto E
        • Tsioufis K
        • Aboyans V
        • Desormais I.
        2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.
        J Hypertens. 2018; 36: 2284-2309
        • Rimoldi SF
        • Scherner U
        • Messerli FH.
        Secondary arterial hypertension: when, who and how to screen?.
        Eur Heart J. 2014; 35: 1245-1254
        • Cingolani OH.
        Cardiovascular risks and organ damage in secondary hypertension.
        Endocrinol Metab Clin North Am. 2019; 48: 657-666
        • Cesari M
        • Letizia C
        • Angeli P
        • Sciomer S
        • Rosi S
        • Rossi GP.
        Cardiac remodeling in patients with primary and secondary aldosteronism: a tissue Doppler study.
        Circ Cardiovasc Imaging. 2016; 9 (Jun)e004815
        • Monticone S
        • D'Ascenzo F
        • Moretti C
        • Williams TA
        • Veglio F
        • Gaita F
        • Mulatero P
        Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
        Lancet Diabetes Endocrinol. 2018; 6: 41-50
      1. Wilkins GE Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
        Can Med Assoc J. 1976; 114: 241-243
        • van Bockel J H
        • van Schilfgaarde R
        • Felthuis W
        • van Brummelen P
        • Terpstra JL.
        Reconstructive surgery for renovascular hypertension secondary to arteriosclerosis and fibro-dysplasia. III. The early and late effects of surgery on hypertensive target organ damage.
        Neth J Med. 1988; 32: 159-171
        • Cuspidi C
        • Dell'Oro R
        • Sala C
        • Tadic M
        • Gherbesi E
        • Grassi G
        • Mancia G
        Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies.
        J Hypertens. 2017; 35: 2339-2345
        • Tsai CH
        • Pan CT
        • Chang YY
        • Chen ZW
        • Wu VC
        • Hung CS
        • Lin YH.
        Left ventricular remodeling and dysfunction in primary aldosteronism.
        J Hum Hypertens. 2021; 35: 131-147
        • YangY Zhu LM
        • Xu JZ
        • Tang XF
        • Gao PJ
        Comparison of left ventricular structure and function in primary aldosteronism and essential hypertension by echocardiography.
        Hypertens Res. 2017; 40: 243-250
        • Saeed S
        • Tadic M
        • Grytaas M
        • Mancia M
        • Larsen TH.
        The value of multimodality imaging in hypertensive heart disease.
        J Hypertens. 2021; 39: 1040-1043
        • Biering-Sørensen T
        • Biering-Sørensen SR
        • Olsen FJ
        • Sengeløv M
        • Jørgensen PG
        • Mogelvang R
        • Shah AM
        • Jensen JS.
        Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen City Heart Study.
        Circ Cardiovasc Imaging. 2017; 10 (Mar)e005521
        • Moher D
        • Liberati A
        • Tetzlaff J
        • Group Altman DG.PRISMA
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ (Clin Res Ed). 2009; 339: b2535
        • Pereira AM
        • Delgado V
        • Romijn JA
        • Smit 1, JA
        • Bax JJ
        • Feelders RA.
        Cardiac dysfunction is reversed upon successful treatment of Cushing’s syndrome.
        Eur J Endocrinol. 2010; 162: 331-340
        • Prejbisz A
        • Florczak E
        • Klisiewicz A
        • Dobrowolski P
        • Janaszek-Sitkowska H
        • Bieleń P
        • Szwench-Pietrasz E
        • Warchoł-Celińska E
        • Kołodziejczyk-Kruk S
        • Janas J
        • Kabat M
        • Imiela J
        • Sliwiński P
        • Januszewicz A.
        Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension.
        Endokrynol Pol Actions. 2013; 64: 363-367
      2. Uziębło-Zyczkowska B, Krzesinski P, Witek P, Zielinski G, Jure A, Gielerak G, Skrobowski A. Cushing's Disease: subclinical left ventricular systolic and diastolic dysfunction revealed by speckle tracking echocardiography and tissue Doppler imaging. Front Endocrinol8:222. doi: 10.3389/fendo.2017.00222.

        • Boulestreau R
        • Cremer A
        • Delarche N.
        • Gosse P.
        Alteration of left ventricular longitudinal systolic function in 2D-strain in primary aldosteronism: a new target organ damage marker.
        Annales de Cardiologie et d’Angéiologie. 2018; 68: 315-320
        • Chen ZW
        • Huang KC
        • Lee JK
        • Lin LC
        • Chen CW
        • Chang YY
        • Liao CW
        • Wu VC
        • Hung CS
        • Lin YH
        • the TAIPAI study group
        Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
        J Hypertens. 2018; 36: 353-360
        • Dobrowolski P
        • Januszewicz M
        • Klisiewicz A
        • Prejbisz A
        • Warchoł-Celinska E
        • Michałowska I
        • et al.
        Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study.
        J Hypertens. 2018; 36: 1318-1325
        • Kvasnicka J
        • Zelinka T
        • Petrák O
        • Rosa J
        • Štrauch B
        • Krátká Z
        • Indra T
        • Markvartová A
        • Widimský Jr, J
        • Holaj R.
        Catecholamines induce left ventricular subclinical systolic dysfunction: a speckle-tracking echocardiography study.
        Cancers. 2019; 11: 318https://doi.org/10.3390/cancers11030318
        • Wang D
        • Xu JZ
        • Chen X
        • Chen Y
        • Shao S
        • Zhang W
        • Zhu LM
        • Xu TY
        • Li Y
        • Wang JG.
        Speckle-tracking echocardiographic layer-specific strain analysis on subclinical left ventricular dysfunction in patients with primary aldosteronism.
        Am J Hypertens. 2019; 32: 155-162
        • Boulestreau R
        • Jambon F
        • Cremer A
        • Doublet J
        • Nunes ML
        • Ferrière A
        • et al.
        Chronic pheochromocytoma-induced myocardial injuries: what should we expect from modern and classical echocardiographic tools?.
        Annales de Cardiologie et d’Angéiologie. 2020; 69: 241-246
        • Dobrowolski P
        • Januszewicz A
        • Klisiewicz A
        • Gosk-Przybyłek M
        • Peczkowska M
        • Kabat M
        • et al.
        Left ventricular structural and functional alterations in patients with pheochromocytoma/paraganglioma before and after surgery.
        JACC Cardiovasc Imaging. 2020; 13: 2499-2507
        • Elenkova A
        • Shabani R
        • Kinova E
        • Vasilev V
        • Assen Goudev A
        • Zacharieva S
        Global longitudinal strain as a marker for systolic function in patients with pheochromocytomas.
        Endocrine-Related Cancer. 2020; 27: 561-570
        • Aune A
        • Kokorina M
        • Grytaas MA
        • Midtbø H
        • Løvås K
        • Gerdts E.
        Preclinical cardiac disease in women and men with primary aldosteronism.
        Blood Press. 2021; (Mar 30Online ahead of print): 1-7https://doi.org/10.1080/08037051.2021.1904775
        • Lang RM
        • Bierig M
        • Devereux RB
        • Flachskampf FA
        • Foster E
        • Pellikka PA
        • Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography
        Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
        J Am Soc Echocardiogr. 2005; 18: 1440-1463
        • Schofer J
        • Tews A
        • Langes K
        • Bleifeld W
        • Reimitz PE
        • Mathey DG.
        Relationship between myocardial norepinephrine content and left ventricular function–an endomyocardial biopsy study.
        Eur Heart J. 1987; 8: 748-753
        • Ferreira VM
        • Marcelino M
        • Piechnik SK
        • Marini C
        • Karamitsos TD
        • Ntusi NAB
        • Francis JM
        • Robson MD
        • Arnold JR
        • Mihai R
        • Thomas JDJ
        • Herincs M
        • Hassan-Smith ZK
        • Greiser A
        • Arlt W
        • Korbonits M
        • Karavitaki N
        • Grossman AB
        • Wass JAH
        • Neubauer S.
        Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction.
        J Am Coll Cardiol. 2016; 67: 2364-2374
        • Hieda M
        • Sarma S
        • Hearon Jr, CM
        • Dias KA
        • Martinez J
        • Samels M
        • Everding B
        • Palmer D
        • Livingston S
        • Morris M
        • Howden E
        • Levine BD.
        Increased myocardial stiffness in patients with high-risk left ventricular hypertrophy: the hallmark of stage-b heart failure with preserved ejection fraction.
        Circulation. 2020; 141: 115-123
        • Yiu KH
        • Marsan NA
        • Delgado V
        • Biermasz NR
        • Holman ER
        • Smit JW
        • Feelders RA
        • Bax JJ
        • Pereira AM.
        Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.
        Eur J Endocrinol. 2012; 166: 27-34
        • Tsai CH
        • Pan CT
        • Chang YY
        • Chen ZW
        • Wu VC
        • Hung CS
        • Lin YH.
        Left ventricular remodeling and dysfunction in primary aldosteronism.
        J Hum Hypertens. 2021; 35: 131-147
        • Roux C
        • Kachenoura N
        • Raissuni Z
        • Mousseaux E
        • Young J
        • Graves MJ
        • Jublanc C
        • Cluzel P
        • Chanson P
        • Kamenický P
        • Redheuil A.
        Effects of cortisol on the heart: characterization of myocardial involvement in Cushing's disease by longitudinal cardiac MRI T1 mapping.
        J Magn Reson Imaging. 2017; 45: 147-156
        • Tadic M
        • Sala C
        • Carugo S
        • Mancia G
        • Grassi G
        • Cuspidi C.
        Myocardial strain and left ventricular geometry: a meta-analysis of echocardiographic studies in systemic hypertension.
        J Hypertens. 2021; (Jun 14Epub ahead of print)https://doi.org/10.1097/HJH.0000000000002911